speb/financial-data huggingface dataset:
FHE.AX income_statement (annual, 2024-12-31) — Special Income Charges: -380692.00
FHE.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 81987964.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 81987964.00
FHE.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 81987964.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 81987964.00
FHE.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
FHE.AX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
FHE.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Assets: 83408038.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Assets: 83408038.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 81987964.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 81987964.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Debt: 57721.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Debt: 57721.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 81271776.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 81271776.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2136262.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2136262.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 67581290.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 67581290.00
FHE.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FHE.AX income_statement (annual, 2024-12-31) — Total Unusual Items: -380692.00
FHE.AX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -380692.00
FHE.AX balance_sheet (annual, 2024-12-31) — Working Capital: 13690486.00
FHE.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 13690486.00
FHE.AX income_statement (annual, 2025-12-31) — +Operating Expense: 4468776.00
FHE.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 782018.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 782018.00
FHE.AX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 7221.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 7221.00
FHE.AX income_statement (annual, 2025-12-31) — Basic Average Shares: 515871687.00
FHE.AX income_statement (annual, 2025-12-31) — Basic EPS: -0.01
FHE.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 14334978.00
FHE.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -9769112.00
FHE.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 128220192.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 128220192.00
FHE.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5587807.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5587807.00
FHE.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5587807.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5587807.00
FHE.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 5587807.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5587807.00
FHE.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 10951029.00
FHE.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -17490797.00
FHE.AX cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -2212156.00
FHE.AX cash_flow (annual, 2025-12-31) — Changes In Cash: -8751924.00
FHE.AX cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -2539207.00
FHE.AX cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 76170.00
FHE.AX balance_sheet (annual, 2025-12-31) — Common Stock: 128220192.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 128220192.00
FHE.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 85511666.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 85511666.00
FHE.AX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 11500000.00
FHE.AX cash_flow (annual, 2025-12-31) — Common Stock Payments: -491250.00
FHE.AX balance_sheet (annual, 2025-12-31) — Current Assets: 5952010.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 5952010.00
FHE.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 5638975.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 5638975.00
FHE.AX balance_sheet (annual, 2025-12-31) — Current Provisions: 60769.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Current Provisions: 60769.00
FHE.AX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 15545.00
FHE.AX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 15545.00
FHE.AX income_statement (annual, 2025-12-31) — Depreciation Income Statement: 15545.00
FHE.AX income_statement (annual, 2025-12-31) — Diluted Average Shares: 515871687.00
FHE.AX income_statement (annual, 2025-12-31) — Diluted EPS: -0.01
FHE.AX income_statement (annual, 2025-12-31) — EBIT: -5156713.00
FHE.AX income_statement (annual, 2025-12-31) — EBITDA: -5141168.00
FHE.AX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 4753.00
FHE.AX cash_flow (annual, 2025-12-31) — End Cash Position: 5587807.00
FHE.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 10951029.00
FHE.AX balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 36089.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 36089.00
FHE.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: -11981268.00
FHE.AX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4048758.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4048758.00
FHE.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 2987110.00
FHE.AX balance_sheet (annual, 2025-12-31) — Gross PPE: 76468247.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 76468247.00
FHE.AX income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 1355358.00
FHE.AX income_statement (annual, 2025-12-31) — Interest Expense: 10996.00
FHE.AX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 10996.00
FHE.AX income_statement (annual, 2025-12-31) — Interest Income: 283521.00
FHE.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 283521.00
FHE.AX cash_flow (annual, 2025-12-31) — Interest Paid Direct: -8350.00
FHE.AX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 8350.00
FHE.AX cash_flow (annual, 2025-12-31) — Interest Received Direct: 259231.00
FHE.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 85511666.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 85511666.00
FHE.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -17490797.00
FHE.AX balance_sheet (annual, 2025-12-31) — Investments And Advances: 8014650.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 8014650.00
FHE.AX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 11500000.00
FHE.AX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 14000000.00
FHE.AX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 14000000.00
FHE.AX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -14057721.00
FHE.AX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 76468247.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 76468247.00
FHE.AX balance_sheet (annual, 2025-12-31) — Minority Interest: -715734.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Minority Interest: -715734.00
FHE.AX income_statement (annual, 2025-12-31) — Minority Interests: -454.00
FHE.AX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 11008750.00
FHE.AX income_statement (annual, 2025-12-31) — Net Income: -5168163.00
FHE.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -5168163.00
FHE.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -5167709.00
FHE.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5168163.00
FHE.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5168163.00
FHE.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -5167709.00
FHE.AX income_statement (annual, 2025-12-31) — Net Interest Income: 272525.00
FHE.AX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -7721685.00
FHE.AX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -57721.00
FHE.AX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -57721.00
FHE.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 272525.00
FHE.AX balance_sheet (annual, 2025-12-31) — Net PPE: 76468247.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 76468247.00
FHE.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -9769112.00
FHE.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 85511666.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 85511666.00
FHE.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -3785810.00
FHE.AX income_statement (annual, 2025-12-31) — Normalized Income: -3812805.00
FHE.AX income_statement (annual, 2025-12-31) — Operating Income: -4468776.00
FHE.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 546572215.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 546572215.00
FHE.AX cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 76170.00
FHE.AX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 4012669.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 4012669.00
FHE.AX income_statement (annual, 2025-12-31) — Other Income Expense: -971458.00
FHE.AX balance_sheet (annual, 2025-12-31) — Other Investments: 8014650.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Other Investments: 8014650.00
FHE.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 383900.00
FHE.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 1466121.00
FHE.AX balance_sheet (annual, 2025-12-31) — Other Payable: 4796188.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 4796188.00
FHE.AX balance_sheet (annual, 2025-12-31) — Other Receivables: 158529.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 158529.00
FHE.AX balance_sheet (annual, 2025-12-31) — Payables: 5578206.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Payables: 5578206.00
FHE.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 5578206.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5578206.00
FHE.AX cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -2539207.00
FHE.AX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 198453.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 198453.00
FHE.AX income_statement (annual, 2025-12-31) — Pretax Income: -5167709.00
FHE.AX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -7721685.00
FHE.AX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -9769112.00
FHE.AX balance_sheet (annual, 2025-12-31) — Receivables: 165750.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 165750.00
FHE.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 15545.00
FHE.AX income_statement (annual, 2025-12-31) — Rent And Landing Fees: 132295.00
FHE.AX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -14057721.00
FHE.AX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -491250.00
FHE.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -46757284.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -46757284.00
FHE.AX income_statement (annual, 2025-12-31) — Salaries And Wages: 2854815.00
FHE.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 2987110.00
FHE.AX balance_sheet (annual, 2025-12-31) — Share Issued: 546572215.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 546572215.00
FHE.AX income_statement (annual, 2025-12-31) — Special Income Charges: -1355358.00
FHE.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 85511666.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 85511666.00
FHE.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 85511666.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 85511666.00
FHE.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
FHE.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
FHE.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
FHE.AX balance_sheet (annual, 2025-12-31) — Total Assets: 90434907.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 90434907.00
FHE.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 85511666.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 85511666.00
FHE.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 84795932.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 84795932.00
FHE.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 5638975.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5638975.00
FHE.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 84482897.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 84482897.00
FHE.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FHE.AX income_statement (annual, 2025-12-31) — Total Unusual Items: -1355358.00
FHE.AX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1355358.00
FHE.AX balance_sheet (annual, 2025-12-31) — Working Capital: 313035.00
FHE.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 313035.00
FHI income_statement (annual, 2021-12-31) — +Operating Expense: 387860000.00
FHI income_statement (annual, 2021-12-31) — Amortization: 13823000.00
FHI income_statement (annual, 2021-12-31) — Amortization Of Intangibles Income Statement: 13823000.00
FHI income_statement (annual, 2021-12-31) — Average Dilution Earnings: -1580000.00
FHI income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 13823000.00
FHI income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 13823000.00
FHI income_statement (annual, 2021-12-31) — General And Administrative Expense: 180333000.00
FHI cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 91925000.00
FHI cash_flow (annual, 2021-12-31) — Issuance Of Debt: 295650000.00
FHI cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 295650000.00
FHI cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -147300000.00
FHI cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 148350000.00
FHI cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 148350000.00
FHI cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -5324000.00
FHI cash_flow (annual, 2021-12-31) — Repayment Of Debt: -147300000.00
FHI income_statement (annual, 2022-12-31) — +Operating Expense: 552239000.00
FHI income_statement (annual, 2022-12-31) — +Total Revenue: 1445814000.00
FHI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 58068000.00
FHI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -119640000.00
FHI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 0.00
FHI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI income_statement (annual, 2022-12-31) — Amortization: 44066000.00
FHI income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 44066000.00
FHI cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 31520000.00
FHI income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
FHI income_statement (annual, 2022-12-31) — Basic Average Shares: 85762000.00
FHI income_statement (annual, 2022-12-31) — Basic EPS: 2.65
FHI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 238051000.00
FHI cash_flow (annual, 2022-12-31) — Capital Expenditure: -4372000.00
FHI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 105203000.00
FHI balance_sheet (annual, 2022-12-31) — Capital Stock: 441142000.00
FHI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 336782000.00
FHI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 521754000.00
FHI cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -97915000.00
FHI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -168513000.00
FHI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -32357000.00
FHI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 323948000.00
FHI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -14825000.00
FHI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 4669000.00
FHI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 18582000.00
FHI cash_flow (annual, 2022-12-31) — Change In Receivables: -4367000.00
FHI cash_flow (annual, 2022-12-31) — Change In Working Capital: 4059000.00
FHI cash_flow (annual, 2022-12-31) — Changes In Cash: 123078000.00
FHI balance_sheet (annual, 2022-12-31) — Common Stock: 441142000.00
FHI cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -97915000.00
FHI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1045692000.00
FHI cash_flow (annual, 2022-12-31) — Common Stock Payments: -218141000.00
FHI income_statement (annual, 2022-12-31) — Cost Of Revenue: 512713000.00
FHI balance_sheet (annual, 2022-12-31) — Current Assets: 651031000.00
FHI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 18394000.00
FHI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 18394000.00
FHI balance_sheet (annual, 2022-12-31) — Current Liabilities: 257413000.00
FHI cash_flow (annual, 2022-12-31) — Deferred Income Tax: -18822000.00
FHI cash_flow (annual, 2022-12-31) — Deferred Tax: -18822000.00
FHI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 28085000.00
FHI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 44066000.00
FHI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 28085000.00
FHI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 44066000.00
FHI income_statement (annual, 2022-12-31) — Diluted Average Shares: 85766000.00
FHI income_statement (annual, 2022-12-31) — Diluted EPS: 2.65
FHI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 227668000.00
FHI balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 35941000.00
FHI income_statement (annual, 2022-12-31) — EBIT: 317295000.00
FHI income_statement (annual, 2022-12-31) — EBITDA: 345380000.00
FHI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -20174000.00
FHI cash_flow (annual, 2022-12-31) — End Cash Position: 340955000.00
FHI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -168513000.00
FHI cash_flow (annual, 2022-12-31) — Free Cash Flow: 319576000.00
FHI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -20190000.00
FHI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -19723000.00
FHI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -45676000.00
FHI income_statement (annual, 2022-12-31) — General And Administrative Expense: 178891000.00
FHI balance_sheet (annual, 2022-12-31) — Goodwill: 800417000.00
FHI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1209538000.00
FHI balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 58089000.00
FHI balance_sheet (annual, 2022-12-31) — Gross PPE: 248243000.00
FHI income_statement (annual, 2022-12-31) — Gross Profit: 933101000.00
FHI income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 44066000.00
FHI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 85579000.00
FHI income_statement (annual, 2022-12-31) — Interest Expense: 11073000.00
FHI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 11073000.00
FHI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 7184000.00
FHI balance_sheet (annual, 2022-12-31) — Invested Capital: 1393273000.00
FHI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -32357000.00
FHI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 488300000.00
FHI balance_sheet (annual, 2022-12-31) — Leases: 40243000.00
FHI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 86809000.00
FHI balance_sheet (annual, 2022-12-31) — Long Term Debt: 347581000.00
FHI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 434390000.00
FHI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 488300000.00
FHI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -361650000.00
FHI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 115140000.00
FHI balance_sheet (annual, 2022-12-31) — Minority Interest: 61821000.00
FHI income_statement (annual, 2022-12-31) — Minority Interests: 4932000.00
FHI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -27985000.00
FHI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -218141000.00
FHI balance_sheet (annual, 2022-12-31) — Net Debt: 10799000.00
FHI income_statement (annual, 2022-12-31) — Net Income: 239496000.00
FHI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 227668000.00
FHI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 234564000.00
FHI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 239496000.00
FHI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 239496000.00
FHI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 234564000.00
FHI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 234564000.00
FHI income_statement (annual, 2022-12-31) — Net Interest Income: -11073000.00
FHI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 126650000.00
FHI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 126650000.00
FHI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11073000.00
FHI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 20893000.00
FHI balance_sheet (annual, 2022-12-31) — Net PPE: 128603000.00
FHI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4372000.00
FHI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -163846000.00
FHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 180410000.00
FHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 180410000.00
FHI income_statement (annual, 2022-12-31) — Normalized EBITDA: 409169000.00
FHI income_statement (annual, 2022-12-31) — Normalized Income: 288358374.00
FHI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 323948000.00
FHI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -15346000.00
FHI income_statement (annual, 2022-12-31) — Operating Income: 380862000.00
FHI income_statement (annual, 2022-12-31) — Operating Revenue: 1445814000.00
FHI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 89284935.00
FHI balance_sheet (annual, 2022-12-31) — Other Current Assets: 8264000.00
FHI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15358000.00
FHI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -45676000.00
FHI income_statement (annual, 2022-12-31) — Other Gand A: 135530000.00
FHI income_statement (annual, 2022-12-31) — Other Income Expense: -63567000.00
FHI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 409121000.00
FHI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 31307000.00
FHI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 40753000.00
FHI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 222000.00
FHI income_statement (annual, 2022-12-31) — Other Operating Expenses: 37863000.00
FHI balance_sheet (annual, 2022-12-31) — Other Properties: 92860000.00
FHI balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 184972000.00
FHI income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 11828000.00
FHI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 73901000.00
FHI balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 149760000.00
FHI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 27004000.00
FHI income_statement (annual, 2022-12-31) — Pretax Income: 306222000.00
FHI balance_sheet (annual, 2022-12-31) — Properties: 0.00
FHI cash_flow (annual, 2022-12-31) — Purchase Of Business: -22644000.00
FHI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4372000.00
FHI balance_sheet (annual, 2022-12-31) — Receivables: 94009000.00
FHI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 512713000.00
FHI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 28085000.00
FHI income_statement (annual, 2022-12-31) — Rent And Landing Fees: 43361000.00
FHI income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 43361000.00
FHI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -361650000.00
FHI cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -218141000.00
FHI balance_sheet (annual, 2022-12-31) — Retained Earnings: 1015589000.00
FHI cash_flow (annual, 2022-12-31) — Sale Of Business: 22770000.00
FHI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 335485000.00
FHI income_statement (annual, 2022-12-31) — Selling General And Administration: 514376000.00
FHI balance_sheet (annual, 2022-12-31) — Share Issued: 99514456.00
FHI income_statement (annual, 2022-12-31) — Special Income Charges: -44066000.00
FHI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 35505000.00
FHI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1045692000.00
FHI balance_sheet (annual, 2022-12-31) — Tangible Book Value: -163846000.00
FHI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -14926626.00
FHI income_statement (annual, 2022-12-31) — Tax Provision: 71658000.00
FHI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
FHI balance_sheet (annual, 2022-12-31) — Total Assets: 2020479000.00
FHI balance_sheet (annual, 2022-12-31) — Total Capitalization: 1393273000.00
FHI balance_sheet (annual, 2022-12-31) — Total Debt: 452784000.00
FHI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1107513000.00
FHI income_statement (annual, 2022-12-31) — Total Expenses: 1064952000.00
FHI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 912966000.00
FHI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1369448000.00
FHI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 655553000.00
FHI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 336796000.00
FHI income_statement (annual, 2022-12-31) — Total Unusual Items: -63789000.00
FHI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -63789000.00
FHI balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 10229521.00
FHI balance_sheet (annual, 2022-12-31) — Treasury Stock: 365363000.00
FHI cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 24383000.00
FHI balance_sheet (annual, 2022-12-31) — Working Capital: 393618000.00
FHI income_statement (annual, 2023-12-31) — +Operating Expense: 644767000.00
FHI income_statement (annual, 2023-12-31) — +Total Revenue: 1609574000.00
FHI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 75721000.00
FHI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -119852000.00
FHI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2000.00
FHI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
FHI income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
FHI income_statement (annual, 2023-12-31) — Basic Average Shares: 83858000.00
FHI income_statement (annual, 2023-12-31) — Basic EPS: 3.40
FHI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 340955000.00
FHI cash_flow (annual, 2023-12-31) — Capital Expenditure: -7915000.00
FHI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 110099000.00
FHI balance_sheet (annual, 2023-12-31) — Capital Stock: 475003000.00
FHI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 383180000.00
FHI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 560675000.00
FHI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -98093000.00
FHI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -243087000.00
FHI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -30610000.00
FHI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 311831000.00
FHI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -19947000.00
FHI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 14627000.00
FHI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 20748000.00
FHI cash_flow (annual, 2023-12-31) — Change In Receivables: -27568000.00
FHI cash_flow (annual, 2023-12-31) — Change In Working Capital: -12140000.00
FHI cash_flow (annual, 2023-12-31) — Changes In Cash: 38134000.00
FHI balance_sheet (annual, 2023-12-31) — Common Stock: 475003000.00
FHI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -98093000.00
FHI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1128252000.00
FHI cash_flow (annual, 2023-12-31) — Common Stock Payments: -177066000.00
FHI income_statement (annual, 2023-12-31) — Cost Of Revenue: 563388000.00
FHI balance_sheet (annual, 2023-12-31) — Current Assets: 720729000.00
FHI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 16283000.00
FHI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 16283000.00
FHI balance_sheet (annual, 2023-12-31) — Current Liabilities: 287343000.00
FHI cash_flow (annual, 2023-12-31) — Deferred Income Tax: 4252000.00
FHI cash_flow (annual, 2023-12-31) — Deferred Tax: 4252000.00
FHI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 26835000.00
FHI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 26835000.00
FHI income_statement (annual, 2023-12-31) — Diluted Average Shares: 83863000.00
FHI income_statement (annual, 2023-12-31) — Diluted EPS: 3.40
FHI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 284999000.00
FHI balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 48694000.00
FHI income_statement (annual, 2023-12-31) — EBIT: 423851000.00
FHI income_statement (annual, 2023-12-31) — EBITDA: 450686000.00
FHI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 7865000.00
FHI cash_flow (annual, 2023-12-31) — End Cash Position: 386954000.00
FHI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -243087000.00
FHI cash_flow (annual, 2023-12-31) — Free Cash Flow: 303916000.00
FHI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -32681000.00
FHI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 35740000.00
FHI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -19911000.00
FHI income_statement (annual, 2023-12-31) — General And Administrative Expense: 198786000.00
FHI balance_sheet (annual, 2023-12-31) — Goodwill: 807156000.00
FHI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1216605000.00
FHI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 75742000.00
FHI balance_sheet (annual, 2023-12-31) — Gross PPE: 249828000.00
FHI income_statement (annual, 2023-12-31) — Gross Profit: 1046186000.00
FHI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 13870000.00
FHI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 108639000.00
FHI income_statement (annual, 2023-12-31) — Interest Expense: 12519000.00
FHI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 12519000.00
FHI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 11648000.00
FHI balance_sheet (annual, 2023-12-31) — Invested Capital: 1476095000.00
FHI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -30610000.00
FHI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
FHI balance_sheet (annual, 2023-12-31) — Leases: 41945000.00
FHI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 93816000.00
FHI balance_sheet (annual, 2023-12-31) — Long Term Debt: 347843000.00
FHI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 441659000.00
FHI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
FHI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
FHI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 108618000.00
FHI balance_sheet (annual, 2023-12-31) — Minority Interest: 25845000.00
FHI income_statement (annual, 2023-12-31) — Minority Interests: -5801000.00
FHI cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -22695000.00
FHI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -177066000.00
FHI income_statement (annual, 2023-12-31) — Net Income: 298980000.00
FHI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 284999000.00
FHI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 304781000.00
FHI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 298980000.00
FHI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 298980000.00
FHI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 304781000.00
FHI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 304781000.00
FHI income_statement (annual, 2023-12-31) — Net Interest Income: -12519000.00
FHI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
FHI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
FHI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -12519000.00
FHI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 32072000.00
FHI balance_sheet (annual, 2023-12-31) — Net PPE: 129976000.00
FHI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -7915000.00
FHI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -88353000.00
FHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 186292000.00
FHI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 186292000.00
FHI income_statement (annual, 2023-12-31) — Normalized EBITDA: 428816000.00
FHI income_statement (annual, 2023-12-31) — Normalized Income: 282775181.34
FHI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 311831000.00
FHI cash_flow (annual, 2023-12-31) — Operating Gains Losses: -32421000.00
FHI income_statement (annual, 2023-12-31) — Operating Income: 401419000.00
FHI income_statement (annual, 2023-12-31) — Operating Revenue: 1609574000.00
FHI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 84849989.00
FHI balance_sheet (annual, 2023-12-31) — Other Current Assets: 5900000.00
FHI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 24378000.00
FHI balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -19911000.00
FHI income_statement (annual, 2023-12-31) — Other Gand A: 153717000.00
FHI income_statement (annual, 2023-12-31) — Other Income Expense: 22432000.00
FHI balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 409449000.00
FHI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 34534000.00
FHI balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 32453000.00
FHI income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 562000.00
FHI income_statement (annual, 2023-12-31) — Other Operating Expenses: 51791000.00
FHI balance_sheet (annual, 2023-12-31) — Other Properties: 99265000.00
FHI balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 177495000.00
FHI income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 13981000.00
FHI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 88290000.00
FHI balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 158392000.00
FHI balance_sheet (annual, 2023-12-31) — Prepaid Assets: 29739000.00
FHI income_statement (annual, 2023-12-31) — Pretax Income: 411332000.00
FHI balance_sheet (annual, 2023-12-31) — Properties: 0.00
FHI cash_flow (annual, 2023-12-31) — Purchase Of Business: -57999000.00
FHI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -7915000.00
FHI balance_sheet (annual, 2023-12-31) — Receivables: 124415000.00
FHI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 563388000.00
FHI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 26835000.00
FHI income_statement (annual, 2023-12-31) — Rent And Landing Fees: 45069000.00
FHI income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 45069000.00
FHI cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
FHI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -177066000.00
FHI balance_sheet (annual, 2023-12-31) — Retained Earnings: 1194561000.00
FHI cash_flow (annual, 2023-12-31) — Sale Of Business: 35304000.00
FHI income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 394190000.00
FHI income_statement (annual, 2023-12-31) — Selling General And Administration: 592976000.00
FHI balance_sheet (annual, 2023-12-31) — Share Issued: 99514456.00
FHI income_statement (annual, 2023-12-31) — Special Income Charges: -13870000.00
FHI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 33947000.00
FHI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1128252000.00
FHI balance_sheet (annual, 2023-12-31) — Tangible Book Value: -88353000.00
FHI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 5665181.34
FHI income_statement (annual, 2023-12-31) — Tax Provision: 106551000.00
FHI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
FHI balance_sheet (annual, 2023-12-31) — Total Assets: 2101844000.00
FHI balance_sheet (annual, 2023-12-31) — Total Capitalization: 1476095000.00
FHI balance_sheet (annual, 2023-12-31) — Total Debt: 457942000.00
FHI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1154097000.00
FHI income_statement (annual, 2023-12-31) — Total Expenses: 1208155000.00
FHI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 947747000.00
FHI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1381115000.00
FHI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 660404000.00
FHI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 387549000.00
FHI income_statement (annual, 2023-12-31) — Total Unusual Items: 21870000.00
FHI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 21870000.00
FHI balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 14664467.00
FHI balance_sheet (annual, 2023-12-31) — Treasury Stock: 521403000.00
FHI cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -13423000.00
FHI balance_sheet (annual, 2023-12-31) — Working Capital: 433386000.00
FHI balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 0.00
FHI cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
FHI income_statement (annual, 2024-12-31) — +Operating Expense: 650779000.00
FHI income_statement (annual, 2024-12-31) — +Total Revenue: 1632093000.00
FHI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 69903000.00
FHI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -118103000.00
FHI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 0.00
FHI balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 0.00
FHI balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 66331000.00
FHI cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
FHI income_statement (annual, 2024-12-31) — Basic Average Shares: 79426000.00
FHI income_statement (annual, 2024-12-31) — Basic EPS: 3.23
FHI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 386954000.00
FHI cash_flow (annual, 2024-12-31) — Capital Expenditure: -4024000.00
FHI cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -505000.00
FHI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 113861000.00
FHI balance_sheet (annual, 2024-12-31) — Capital Stock: 503524000.00
FHI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 504441000.00
FHI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 641042000.00
FHI cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -184811000.00
FHI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -286397000.00
FHI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 64251000.00
FHI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 346554000.00
FHI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -29003000.00
FHI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 9359000.00
FHI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 19871000.00
FHI cash_flow (annual, 2024-12-31) — Change In Receivables: 17348000.00
FHI cash_flow (annual, 2024-12-31) — Change In Working Capital: 17575000.00
FHI cash_flow (annual, 2024-12-31) — Changes In Cash: 124408000.00
FHI balance_sheet (annual, 2024-12-31) — Common Stock: 503524000.00
FHI cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -184811000.00
FHI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1095206000.00
FHI cash_flow (annual, 2024-12-31) — Common Stock Payments: -137615000.00
FHI income_statement (annual, 2024-12-31) — Cost Of Revenue: 540486000.00
FHI balance_sheet (annual, 2024-12-31) — Current Assets: 781352000.00
FHI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 16695000.00
FHI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 16695000.00
FHI balance_sheet (annual, 2024-12-31) — Current Liabilities: 289193000.00
FHI cash_flow (annual, 2024-12-31) — Deferred Income Tax: -14935000.00
FHI cash_flow (annual, 2024-12-31) — Deferred Tax: -14935000.00
FHI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 22429000.00
FHI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 22429000.00
FHI income_statement (annual, 2024-12-31) — Diluted Average Shares: 79430000.00
FHI income_statement (annual, 2024-12-31) — Diluted EPS: 3.23
FHI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 256709000.00
FHI balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 36317000.00
FHI income_statement (annual, 2024-12-31) — EBIT: 394274000.00
FHI income_statement (annual, 2024-12-31) — EBITDA: 416703000.00
FHI cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -3795000.00
FHI cash_flow (annual, 2024-12-31) — End Cash Position: 507567000.00
FHI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -286397000.00
FHI cash_flow (annual, 2024-12-31) — Free Cash Flow: 342530000.00
FHI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -36579000.00
FHI income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 32668000.00
FHI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -32083000.00
FHI income_statement (annual, 2024-12-31) — General And Administrative Expense: 210814000.00
FHI balance_sheet (annual, 2024-12-31) — Goodwill: 804818000.00
FHI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1132699000.00
FHI balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 69924000.00
FHI balance_sheet (annual, 2024-12-31) — Gross PPE: 248378000.00
FHI income_statement (annual, 2024-12-31) — Gross Profit: 1091607000.00
FHI income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 79361000.00
FHI cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 125870000.00
FHI income_statement (annual, 2024-12-31) — Interest Expense: 12665000.00
FHI income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 12665000.00
FHI cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 11592000.00
FHI balance_sheet (annual, 2024-12-31) — Invested Capital: 1443312000.00
FHI cash_flow (annual, 2024-12-31) — Investing Cash Flow: 64251000.00
FHI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
FHI balance_sheet (annual, 2024-12-31) — Leases: 41764000.00
FHI balance_sheet (quarterly, 2024-12-31) — Leases: 41764000.00
FHI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 97166000.00
FHI balance_sheet (annual, 2024-12-31) — Long Term Debt: 348106000.00
FHI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 445272000.00
FHI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
FHI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
FHI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 101904000.00
FHI balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 101904000.00
FHI balance_sheet (annual, 2024-12-31) — Minority Interest: 55514000.00
FHI income_statement (annual, 2024-12-31) — Minority Interests: -116000.00
FHI cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 72375000.00
FHI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -137615000.00
FHI income_statement (annual, 2024-12-31) — Net Income: 268314000.00
FHI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 256709000.00
FHI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 268430000.00
FHI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 268314000.00
FHI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 268314000.00
FHI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 268430000.00
FHI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 268430000.00
FHI income_statement (annual, 2024-12-31) — Net Interest Income: -12665000.00
FHI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
FHI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
FHI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -12665000.00
FHI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 36029000.00
FHI cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -4100000.00
FHI cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
FHI balance_sheet (annual, 2024-12-31) — Net PPE: 130275000.00
FHI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4024000.00
FHI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -37493000.00
FHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 170957000.00
FHI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 170957000.00